{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:23:36Z","timestamp":1790681016743,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochirurgie"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.neuchi.2017.12.006","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T10:08:53Z","timestamp":1534241333000},"page":"28-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["M\u00e9dulloblastome. Anatomie pathologique"],"prefix":"10.1016","volume":"67","author":[{"given":"A.","family":"Siegfried","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-B.","family":"Delisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuchi.2017.12.006_bib0005","series-title":"WHO classification of tumours of the central nervous system","author":"Louis","year":"2007"},{"key":"10.1016\/j.neuchi.2017.12.006_bib0010","series-title":"WHO classification of tumours of the central nervous system","author":"Louis","year":"2016"},{"issue":"6","key":"10.1016\/j.neuchi.2017.12.006_bib0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5414\/NP300999","article-title":"Update on the integrated histopathological and genetic classification of medulloblastoma \u2013\u00a0a practical diagnostic guideline","volume":"35","author":"Pietsch","year":"2016","journal-title":"Clin Neuropathol"},{"issue":"4","key":"10.1016\/j.neuchi.2017.12.006_bib0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: the current consensus","volume":"123","author":"Taylor","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.neuchi.2017.12.006_bib0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nrc3410","article-title":"Medulloblastomics: the end of the beginning","volume":"12","author":"Northcott","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neuchi.2017.12.006_bib0030","first-page":"31","article-title":"Tumeurs embryonnaires du syst\u00e8me nerveux central\u00a0: approche g\u00e9n\u00e9tique","volume":"1","author":"Siegfried","year":"2016","journal-title":"Correspondances en Oncotheranostic"},{"issue":"1","key":"10.1016\/j.neuchi.2017.12.006_bib0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/path.2514","article-title":"Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics","volume":"218","author":"Fattet","year":"2009","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.neuchi.2017.12.006_bib0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/nan.12161","article-title":"Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours","volume":"41","author":"Goschzik","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"35","key":"10.1016\/j.neuchi.2017.12.006_bib0045","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1200\/JCO.2010.31.1670","article-title":"TP53\u00a0mutation is frequently associated with CTNNB1\u00a0mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma","volume":"28","author":"Pfaff","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.neuchi.2017.12.006_bib0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-011-0800-8","article-title":"Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH\/WNT molecular subgroups","volume":"121","author":"Ellison","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.neuchi.2017.12.006_bib0055","first-page":"221","article-title":"Histological and genetic methods to evaluate molecular profiles in medulloblastoma. Prognostic relevance","volume":"35","author":"Delisle","year":"2016","journal-title":"Clin Neuropathol"},{"issue":"3","key":"10.1016\/j.neuchi.2017.12.006_bib0060","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bpa.12293","article-title":"Integrating molecular subclassification of medulloblastomas into routine clinical practice: a simplified approach","volume":"26","author":"Kaur","year":"2016","journal-title":"Brain Pathol"},{"issue":"8","key":"10.1016\/j.neuchi.2017.12.006_bib0065","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1200\/JCO.2009.23.5952","article-title":"Universal poor survival in children with medulloblastoma harboring somatic TP53\u00a0mutations","volume":"28","author":"Tabori","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.neuchi.2017.12.006_bib0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5414\/NP300205","article-title":"Clinical, pathological, and molecular data on desmoplastic\/nodular medulloblastoma: case studies and a review of the literature","volume":"35","author":"Siegfried","year":"2016","journal-title":"Clin Neuropathol"},{"issue":"33","key":"10.1016\/j.neuchi.2017.12.006_bib0075","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2010.30.2299","article-title":"Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis","volume":"28","author":"Rutkowski","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.neuchi.2017.12.006_bib0080","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/1078-0432.CCR-10-2210","article-title":"Rapid diagnosis of medulloblastoma molecular subgroups","volume":"17","author":"Schwalbe","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.neuchi.2017.12.006_bib0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2014.02.004","article-title":"Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition","volume":"25","author":"Kool","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neuchi.2017.12.006_bib0090","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12322","article-title":"Medulloblastoma with extensive nodularity: a tumor exclusively of infancy?","author":"Gessi","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.neuchi.2017.12.006_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-014-1276-0","article-title":"Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000\u00a0multicenter clinical trial cohort","volume":"128","author":"Pietsch","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.neuchi.2017.12.006_bib0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","article-title":"Risk stratification of childhood medulloblastoma in the molecular era: the current consensus","volume":"131","author":"Ramaswamy","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"9","key":"10.1016\/j.neuchi.2017.12.006_bib0105","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/pbc.26042","article-title":"Clinical, pathological, and molecular characterization of infant medulloblastomas treated with sequential high-dose chemotherapy","volume":"63","author":"Lafay-Cousin","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.neuchi.2017.12.006_bib0110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12254-012-0037-9","article-title":"Update on molecular and genetic alterations in adult medulloblastoma","volume":"5","author":"Kool","year":"2012","journal-title":"Memo"},{"issue":"7","key":"10.1016\/j.neuchi.2017.12.006_bib0115","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/neuonc\/now050","article-title":"Molecular subgroups of adult medulloblastoma: a long-term single-institution study","volume":"18","author":"Zhao","year":"2016","journal-title":"Neuro Oncol"},{"issue":"18","key":"10.1016\/j.neuchi.2017.12.006_bib0120","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2009.25.7121","article-title":"Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification","volume":"28","author":"Korshunov","year":"2010","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.neuchi.2017.12.006_bib0125","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.ejca.2015.06.124","article-title":"Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000\u00a0protocol","volume":"51","author":"von Bueren","year":"2015","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.neuchi.2017.12.006_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5414\/NP300636","article-title":"Embryonal tumor with multilayered rosettes: diagnostic tools update and review of the literature","volume":"33","author":"Ceccom","year":"2014","journal-title":"Clin Neuropathol"},{"issue":"8","key":"10.1016\/j.neuchi.2017.12.006_bib0135","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S1470-2045(12)70257-7","article-title":"Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis","volume":"13","author":"Picard","year":"2012","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.neuchi.2017.12.006_bib0140","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-012-1068-3","article-title":"LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)","volume":"124","author":"Korshunov","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.neuchi.2017.12.006_bib0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-014-1291-1","article-title":"CNS-PNETs with C19MC amplification and\/or LIN28\u00a0expression comprise a distinct histogenetic diagnostic and therapeutic entity","volume":"128","author":"Spence","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.neuchi.2017.12.006_bib0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00381-015-2920-2","article-title":"Embryonal tumors with multilayered rosettes in children: the SFCE experience","volume":"32","author":"Horwitz","year":"2016","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"10.1016\/j.neuchi.2017.12.006_bib0155","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New brain tumor entities emerge from molecular classification of CNS-PNETs","volume":"164","author":"Sturm","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.neuchi.2017.12.006_bib0160","doi-asserted-by":"crossref","first-page":"984","DOI":"10.5858\/2010-0515-OAR1","article-title":"Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study","volume":"135","author":"McLendon","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.neuchi.2017.12.006_bib0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/gcc.22018","article-title":"High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1\u00a0aberrations in atypical teratoid\/rhabdoid tumors","volume":"52","author":"Hasselblatt","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.neuchi.2017.12.006_bib0170","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/PAS.0b013e3182196a39","article-title":"Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid\/rhabdoid tumor showing retained SMARCB1 (INI1) expression","volume":"35","author":"Hasselblatt","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.neuchi.2017.12.006_bib0175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccell.2016.02.001","article-title":"Atypical teratoid\/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes","volume":"29","author":"Johann","year":"2016","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.neuchi.2017.12.006_bib0180","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ccell.2016.11.003","article-title":"Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors","volume":"30","author":"Torchia","year":"2016","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.neuchi.2017.12.006_bib0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5414\/NP300942","article-title":"Malignant glioma with primitive neuroectodermal tumor-like component (MG-PNET): novel microarray findings in a pediatric patient","volume":"35","author":"Liu","year":"2016","journal-title":"Clin Neuropathol"},{"issue":"2","key":"10.1016\/j.neuchi.2017.12.006_bib0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/bpa.12023","article-title":"Chromatin remodeling defects in pediatric and young adult glioblastoma: a tale of a variant histone 3\u00a0tail","volume":"23","author":"Fontebasso","year":"2013","journal-title":"Brain Pathol"},{"issue":"18","key":"10.1016\/j.neuchi.2017.12.006_bib0195","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"Paugh","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7663","key":"10.1016\/j.neuchi.2017.12.006_bib0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature22973","article-title":"The whole-genome landscape of medulloblastoma subtypes","volume":"547","author":"Northcott","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuchi.2017.12.006_bib0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00401-012-1077-2","article-title":"DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies","volume":"125","author":"Schwalbe","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.neuchi.2017.12.006_bib0210","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","article-title":"Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study","volume":"18","author":"Schwalbe","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.neuchi.2017.12.006_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.05.005","article-title":"Intertumoral heterogeneity within medulloblastoma subgroups","volume":"31","author":"Cavalli","year":"2017","journal-title":"Cancer Cell"}],"container-title":["Neurochirurgie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377018300122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377018300122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:31:55Z","timestamp":1758436315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028377018300122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0028377018300122"],"URL":"https:\/\/doi.org\/10.1016\/j.neuchi.2017.12.006","relation":{},"ISSN":["0028-3770"],"issn-type":[{"value":"0028-3770","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9dulloblastome. Anatomie pathologique","name":"articletitle","label":"Article Title"},{"value":"Neurochirurgie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuchi.2017.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}